EP 4232046 A4 20231108 - PHARMACEUTICAL COMPOSITIONS PREPARED BY DRY MILLING METHOD AND CONTAINING CELECOXIB WITH INCREASED DISSOLUTION RATE
Title (en)
PHARMACEUTICAL COMPOSITIONS PREPARED BY DRY MILLING METHOD AND CONTAINING CELECOXIB WITH INCREASED DISSOLUTION RATE
Title (de)
DURCH TROCKENMAHLVERFAHREN HERGESTELLTE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT CELECOXIB MIT ERHÖHTER AUFLÖSUNGSGESCHWINDIGKEIT
Title (fr)
COMPOSITIONS PHARMACEUTIQUES PRÉPARÉES PAR BROYAGE À SEC ET CONTENANT DU CÉLÉCOXIB À VITESSE DE DISSOLUTION ACCRUE
Publication
Application
Priority
- TR 202017034 A 20201026
- TR 2021050619 W 20210617
Abstract (en)
[origin: WO2021230849A1] The invention relates to a pharmaceutical composition prepared by dry milling containing celecoxib or pharmaceutically acceptable salt or hydrate thereof, povidone, mannitol and at least one pharmaceutically acceptable excipient and the weight ratio of celocoxib : povidone : mannitol in this composition, the celecoxib particle size and the dissolution rate of the composition.
IPC 8 full level
A61K 31/635 (2006.01); A61K 9/14 (2006.01); A61K 31/415 (2006.01)
CPC (source: EP)
A61K 9/145 (2013.01); A61K 9/146 (2013.01); A61K 31/415 (2013.01); A61K 31/635 (2013.01)
Citation (search report)
- [XYI] CN 110840850 A 20200228 - YANTAI INST OF MATERIA MEDICA
- [Y] WO 2010121321 A1 20101028 - ICEUTICA PTY LTD [AU], et al
- [A] CN 102988296 A 20130327 - JIANGSU HENGRUI MEDICINE CO
- See references of WO 2021230849A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021230849 A1 20211118; EP 4232046 A1 20230830; EP 4232046 A4 20231108; TR 202017034 A2 20210921
DOCDB simple family (application)
TR 2021050619 W 20210617; EP 21803262 A 20210617; TR 202017034 A 20201026